About the Editors
Chief Editor: Alexia-Ileana Zaromytidou, PhD, Springer Nature, USA ORCID
Alexia completed her BSc in Molecular Biology at University College London, followed by a PhD in Biochemistry in the laboratory of Richard Treisman at the London Research Institute of Cancer Research UK (now the Francis Crick Institute) in London, UK. She carried out her postdoctoral research in the lab of Joan Massagué at Memorial Sloan Kettering Cancer Center in New York. She joined the Nature Cell Biology editorial team in 2010, championing cancer biology as a major field at the journal, and was later promoted to Chief Editor, overseeing the expansion of the journal’s scope and editorial team. After working on a publishing proposal for a new cancer-dedicated Nature journal in 2018, she took the helm of Nature Cancer as its launch Chief Editor in 2019. During her editorial career Alexia has handled thousands of manuscripts across preclinical, translational and clinical research and has contributed to the development of several editorial & publishing policies of the Nature Portfolio. She is an active member of the scientific community, having co-organized a large number of scientific conferences, and delivering numerous talks and workshops every year to advise researchers on matters pertaining to their work, best scientific practice and science policy. Alexia is based in New York.
Email: a.zaromytidou@nature.com | X: @alexia_zz
Senior Editor: Lisa Hoffmann-Haas, PhD, Springer Nature, Germany
Lisa obtained her master’s degree from the University of Vienna, during which she was trained in the laboratory of Jacqui Shields at the MRC Cancer Unit in Cambridge, UK. She then completed her PhD in the laboratory of Anna Obenauf at the Institute of Molecular Pathology (IMP) in Vienna, Austria. Her doctoral research was based on the intersection of targeted therapy and immunotherapy and focused on understanding the effects of acquired resistance to targeted therapy on the tumor microenvironment. She joined Nature Cancer in 2021 and is based in the Berlin office.
Email: lisa.haas@nature.com | X: @LisaHaas0107
Associate Editor: Ioanna Pavlaki, PhD, Springer Nature, Germany
Ioanna completed her Master´s and PhD degrees in Molecular Medicine at the University of Essex (UK), where she trained in the Molecular Oncology laboratory of Elena Klenova. Her PhD thesis focused on the effect of post-translational modifications of transcription factors on gene expression regulation. She then carried out postdoctoral work in the laboratory of Keith Vance at the University of Bath (UK) studying lncRNA biology and chromatin architecture. Subsequently, she worked as a postdoctoral research fellow in R-loop biology in the laboratory of Christof Niehrs, at the Institute of Molecular Biology (Mainz, Germany). She joined Nature Cancer in October 2021 and is based in the Berlin office.
Email: ioanna.pavlaki@nature.com
Senior Editor: Eleni Skourti, PhD, Springer Nature, UK ORCID
Eleni obtained her master’s degree from the University of Athens, with her thesis focusing on the role of miRNAs in skin cancer. She completed her PhD at the Rayne Institute in King’s College London, where she developed tools to image miRNAs and to trace hypoxic events in breast cancer. Subsequently, she conducted post-doctoral research in the Telomere Stability group at the London Institute of Medical Sciences, Imperial College London, where she studied telomeric factors that drive mechanisms involved in the alternative lengthening of telomeres (ALT) in cancer cells. She then joined The FEBS Journal editorial team in 2021. Eleni joined Nature Cancer in November 2023 and is based in the London office.
Email: eleni.skourti@nature.com | X: @skourti_elena
Associate Editor: Julieta Alfonso, PhD, Springer Nature, Germany ORCID
Julieta studied Biology and completed her PhD in Molecular Biology and Biotechnology in the lab of Prof. Alberto Carlos Frasch in Argentina. She moved to Germany to work as a postdoc in Prof. Hannah Monyer’s lab at the University Hospital Heidelberg, where she focused on postnatal neurogenesis in mammalian models. She established her group at the Department of Clinical Neurobiology, German Cancer Research Center (DKFZ) in 2014. Her team investigated molecular and cellular mechanisms involved in neural cell proliferation and migration in brain development and malignant growth. Specifically, her group focused on the interaction between the vascular and nervous systems in the developing brain and lipid metabolic pathways in glioblastoma. She joined Nature Cancer in 2024 and is based in Heidelberg, Germany.
Email: julieta.alfonso@nature.com
Associate Editor: Tiffanie Chouleur, PhD, Springer Nature, UK ORCID
Tiffanie obtained her PhD in Cell Biology and Pathophysiology from the University of Bordeaux, France and McGill University, Canada as part of a co-tutelle program. She studied the role of protein tyrosine phosphatases in the progression of glioblastoma and the modulation of tumor microenvironment. In parallel, Tiffanie worked on establishing signatures that predict recurrence in patients with IDH-mutant glioma using multi-omic datasets. She joined Nature Cancer in March 2024 and is based in the London office.
Email: tiffanie.chouleur@nature.com
The Research Cross-Journal Editorial Team supports the Nature-branded research journals, with a focus on handling primary research manuscripts.
The Reviews Cross-Journal Editorial Team handles Research Briefing articles for the Nature-branded research journals.
